Payments to Healthcare Professionals
AstraZeneca believes that providing information to the public about our company, our medicines and how we do business serves the best interests of patients
The medicines we discover and develop and the interactions we have play an integral role in the Australian healthcare system. We view the way we conduct our business as a great responsibility for our company and all of our employees, and it is critically important to us that the public trusts our ability to carry out this responsibility ethically and in the best interest of patient health.
We hope that by being open about how we conduct our business, about the safety and risks of our medicines, about our interactions with healthcare professionals, we can help to earn this trust and continue with our mission of helping to improve patients' health through meaningful medicines.
As a member of Medicines Australia, AstraZeneca has undertaken to be open and transparent when we provide a reportable payment of transfer of value to a healthcare professional. Reportable payments or transfers of value are:
- Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant
- Airfares, accommodation and/or conference registration fees to attend medical education as part of the provision or services or as a participant.
AstraZeneca has prepared a report for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and Australia's Privacy legislation. The report identifies healthcare professionals by name, where their consent has been provided. Where consent has not been provided, the information is reported in aggregate.
From 1 October 2016, reporting these payments will be mandatory - details will be reported because Healthcare Professionals should reasonably expect that all reportable payments or transfers of value will be disclosed for each healthcare professional, by name.
From 30 August 2019, this information will now be held in a database, administered by Medicines Australia. This database is designed to be searchable as well as downloaded as a CSV file. For further information about the details in the report, or to search the database, please visit www.DisclosureAustralia.com.au
To comply with our privacy obligations, reports may be amended from time to time to contain the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988. For further information about the details in the report, please go to www.medicinesaustralia.com.au
These reports will be available for at least three years from the date of publication.